Skip to main content
. 2018 Oct 8;32(2):doy091. doi: 10.1093/dote/doy091

Table 1.

Clinicopathological characteristics

Total (n = 60) IMT (n = 28) Control (n = 32) p-value
Demographics
Age (mean (SD) years) 64.13 (7.8) 63.07 (8.8) 65.06 (67.78) 0.33
Gender (n (%))
 Male 42 (70) 20 22 0.82
 Female 18 8 10
Height (mean (SD) cm) 166.22 (16.45) 167.93 (14.27) 164.72 (18.22) 0.46
Weight (mean (SD) kg) 80.68 (18.62) 81.91 (16.27) 79.60 (20.64) 0.64
Clinical details
Tumor histology (n (%))
 Adenocarcinoma 42 (70) 21 (75) 21 (66) 0.43
 Squamous cell carcinoma 18 (30) 7 (25) 11 (34)
Neoadjuvant therapy (n (%))
 CROSS 30 (50) 16 (57) 14 (44) 0.56
 MAGIC 15 (25) 6 (21.5) 9 (28)
 None 15 (25) 6 (21.5) 9 (28)
ASA Score (n (%))
 1 7 (12) 4 (14) 3 (9) N/A
 2 38 (63) 18 (64) 20 (63)
 3 13 (22) 4 (14) 9 (28)
 4 2 (3) 2 (7) 0
Operative details
Surgical approach (n (%))
 Transthoracic 43 (72) 22 (79) 21 (66) 0.27
 Transhiatial 17 (28) 6 (21) 11 (33)
Surgery duration (median (IQR) hours) 5.0 (1.19) 5.0 (1.5) 5.0 (1.4) 0.32
Blood loss (median (IQR) mLs) 742.93 (475.03) 757.59 (493.16) 729.06 (465.85) 0.93
Postoperative recovery
Hospital LOS (median (IQR) days) 17.5 (13.0) 17.0 (8.0) 18.0 (15) 0.87
Critical care LOS (median (IQR) days) 4.0 (3.0) 4.0 (3.75) 4.0 (2.75) 1.00
Intubated (n (%)) 7 (12) 3 (11) 4 (13) N/A
Postoperative complications (n (%))
 Pulmonary complications 20 (33) 9 (32) 11 (34) 0.86
 Anastomotic leak 2 (3) 1 (3.6) 1 (3.1) 1.00
 Vocal cord paralysis 2 (3) 0 2 (6.3) 0.49
 Chyle leak 3 (5) 3 (11) 0 0.09
 Wound infection 6 (10) 3 (11) 3 (9) 1.00
 Cardiac complications 9 (15) 3 (11) 6 (19) 0.48
CCI (median (IQR) score) 8.7 (20.9) 0.0 (20.9) 8.7 (26.2) 0.31
In-hospital mortality (n (%)) 0 0 0 N/A

P-value for difference between groups at baseline. P-value = N/A data violated assumptions for Chi-Squared analysis. ASA, American Society of Anaesthesiologists; CCI, comprehensive complications index; IQR, interquartile range; LOS, length of stay; SD, standard deviation;